Henrik Brorsson

Novo Nordisk Farma Oy provides diabetes care services. The firm also engages in development of haemophilia care, growth hormone therapy and menopausal hormone therapy. The company was founded in 1972 and is headquartered in Espoo, Finland.

Novo Nordisk Pharma AG engages in the research, development, production, and distribution of products for the treatment of diabetes. It also specializes in the areas of obesity, blood coagulation, as well as growth hormones and hormone replacement therapy. The company was founded on February 17, 1930 and is headquartered in Zurich, Switzerland.

Novo Nordisk Ltd. engages in the sale and marketing of pharmaceutical products for the treatment of chronic conditions in the United Kingdom. It offers medicines for the treatment of diabetes, and hemophilia and bleeding disorders, as well as for growth hormone therapy and hormone replacement therapy. The company is headquartered in Crawley, the United Kingdom.

Novo Nordisk Region International Operations A/S holds ownership interests in companies that operates within investment and financing activities. The firm also invests capital in companies and real estate. The company was founded in January 1, 2002 and is headquartered in Bagsvaerd, Denmark.

bioMASON, Inc. operates as a biotechnology manufacturing company that serves the building and construction industry. It offers concrete, glass, steel, and wood. The company was founded by Ginger Krieg Dosier in 2012 and is headquartered in Research Triangle Park, NC.

Part of FLSmidth & Co. A/S, FLSmidth A/S is a Danish company that provides flowsheet technology services. The company is based in Valby, Denmark. The company was founded in 1991 by Ole Falvig Ramsby, Birger Riisager. The CEO is Mikko Juhani Keto.